Sqi Diagnostics Stock Gross Profit
| SQIDFDelisted Stock | USD 0.01 0.00 0.00% |
SQI Diagnostics fundamentals help investors to digest information that contributes to SQI Diagnostics' financial success or failures. It also enables traders to predict the movement of SQI Pink Sheet. The fundamental analysis module provides a way to measure SQI Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SQI Diagnostics pink sheet.
SQI |
SQI Diagnostics Company Gross Profit Analysis
SQI Diagnostics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current SQI Diagnostics Gross Profit | 3.1 M |
Most of SQI Diagnostics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, SQI Diagnostics reported 3.1 M of gross profit. This is 99.86% lower than that of the Health Care Equipment & Supplies sector and 99.65% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.99% higher than that of the company.
SQI Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SQI Diagnostics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SQI Diagnostics could also be used in its relative valuation, which is a method of valuing SQI Diagnostics by comparing valuation metrics of similar companies.SQI Diagnostics is currently under evaluation in gross profit category among its peers.
SQI Fundamentals
| Return On Equity | -12.54 | |||
| Return On Asset | -0.94 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (1.71) % | |||
| Current Valuation | 34.24 M | |||
| Shares Outstanding | 406.25 M | |||
| Shares Owned By Insiders | 51.02 % | |||
| Shares Owned By Institutions | 24.31 % | |||
| Price To Earning | (2.35) X | |||
| Price To Book | 16.12 X | |||
| Price To Sales | 3.91 X | |||
| Revenue | 8.1 M | |||
| Gross Profit | 3.1 M | |||
| EBITDA | (12.12 M) | |||
| Net Income | (18.52 M) | |||
| Cash And Equivalents | 3.96 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 6.3 M | |||
| Debt To Equity | 4.64 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (9.82 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 21 | |||
| Beta | -0.0648 | |||
| Market Capitalization | 34.43 M | |||
| Total Asset | 9.31 M | |||
| Retained Earnings | (55.6 M) | |||
| Working Capital | 1.09 M | |||
| Current Asset | 1.67 M | |||
| Current Liabilities | 584 K | |||
| Z Score | -7.3 | |||
| Net Asset | 9.31 M |
About SQI Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SQI Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SQI Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SQI Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in SQI Pink Sheet
If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |